GF Fund Management’s Inozyme Pharma INZY Stock Holding History

GF Fund Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,544	Closed	-$6.18K	–	657
2025 Q2	$6.18K	Hold	1,544	–	–	﹤0.01%	613
2025 Q1	$1.41K	Buy	1,544 +195	+14%	+$270	﹤0.01%	656
2024 Q4	$3.74K	Buy	+1,349	New	+$5.13K	﹤0.01%	621

GF Fund Management's INZY Position: Q3 2025 in Review

GF Fund Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 1,544 shares — an estimated $6.18K sold.

GF Fund Management first reported a position in INZY in Q4 2024 and held it in 3 quarters. The position peaked at $6.18K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

GF Fund Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
GF Fund Management sold 1,544 Inozyme Pharma shares in Q3 2025, an estimated $6.18K.
GF Fund Management first reported a position in Inozyme Pharma in Q4 2024 and held it in 3 quarters.
GF Fund Management's Inozyme Pharma position peaked at $6.18K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.